Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SETPOINT Study: Early vs. Deferred ART in Newly Infected HIV-1
NCT00090779Phase 2Terminated
- Start
- Jan 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil, lopinavir + ritonavir in human immunodeficiency virus infection (HIV). Started Jan 2005; status: terminated.
02
Drugs
emtricitabine + tenofovir disoproxillopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00090779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090779.